NCT03941665View on ClinicalTrials.gov

Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

May 1, 2020

Study Completion Date

May 3, 2020

Conditions
Radiation Dermatitis
Interventions
DEVICE

Gelronate

Gel for topical use

OTHER

Aloevera

Gel for topical use

Trial Locations (1)

5265601

Sheba Medical Center, Ramat Gan

Sponsors

Collaborators (1)

Ferring Pharmaceuticals
All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Sheba Medical Center

OTHER_GOV

NCT03941665 - Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients | Biotech Hunter | Biotech Hunter